Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivoRashmi Rajappa, SubbaRao V. Madhunapantula|Frontiers in Pharmacology|2019Cited by 71